The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A series of combinations of deaminase, reverse transcriptase (RT), or a transcriptional repressor/activator with Cas9 subsequently achieved unprecedented benefits, such as the expression/activation of specific or multiple genes, DNA base pair conversions, or transversions.413,414”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Kunitski, M., Eicke, N., Huber, P., Köhler, J., Zeller, S., Voigtsberger, J., Schlott, N., Henrichs, K., Sann, H., Trinter, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07882-8 · Cited by 8,162
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · cited 1×
“The CRISPR/ Cas system awarded its developers the Noble Prize influencing the world of molecular biology and medicine [1].”
BackgroundProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184 · cited 1×
“According to the inventors of the prime editors, this state-of-the-art technology offers greater versatility than CRISPR nucleases [68, 69] and base editors [10, 12], and it has the capability to correct up to 89% of the > 75,000 pathogenic human genetic variants reported in ClinVar [13, 70].”
BackgroundCRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“Further, dCas9 has been used for a variety of applications, including transcriptional modulation, epigenome editing, and imaging loci [32, 33].”
MethodAdeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Research works printed but not linked: 62
- Gallagher, D. N., & Haber, J. E. (2018). Repair of a site-specific DNA cleavage: Old-school lessons for Cas9-mediated gene editing. ACS Chemical Biology, 13(2), 397–405. · DOI
- Rouet, P., Smih, F., & Jasin, M. (1994). Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Molecular and Cellular Biology, 14(12), 8096–8106.
- Mao, Z., Bozzella, M., Seluanov, A., & Gorbunova, V. (2008). Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair, 7(10), 1765–1771. · DOI · Paper page
- Song, F., & Stieger, K. (2017). Optimizing the DNA donor template for homology-directed repair of double-strand breaks. Molecular Therapy-Nucleic Acids, 7, 53–60. · DOI
- Bollen, Y., Post, J., Koo, B. K., & Snippert, H. J. (2018). How to create state-of-the-art genetic model systems: Strategies for optimal CRISPR-mediated genome editing. Nucleic Acids Research, 46(13), 6435–6454. · DOI
- Komor, A. C., Badran, A. H., & Liu, D. R. (2017). CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell, 168(1–2), 20–36. · DOI · Paper page
- Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., & Raguram, A. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576(7785), 149–157. · DOI · Paper page
- Wang, D., Zhang, F., & Gao, G. (2020). CRISPR-based therapeutic genome editing: Strategies and in vivo delivery by AAV vectors. Cell, 181(1), 136–150. · DOI · Paper page
- Thurtle-Schmidt, D. M. (2018). Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates. Biochemistry and Molecular Biology Education, 46(2), 195–205. · DOI · Paper page
- Li, Q., Qin, Z., Wang, Q., Xu, T., Yang, Y., & He, Z. (2019). Applications of genome editing technology in animal disease modeling and gene therapy. Computational and Structural Biotechnology Journal, 17, 689–698. · DOI
- Khan, S. H. (2019). Genome-editing technologies: Concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. Molecular Therapy-Nucleic Acids, 16, 326–334. · DOI · Paper page
- Aubert, M., Strongin, D. E., Roychoudhury, P., Loprieno, M. A., Haick, A. K., Klouser, L. M., Stensland, L., Huang, M.-L., Makhsous, N., & Tait, A. (2020). Gene editing and elimination of latent herpes simplex virus in vivo. Nature Communications, 11(1), 1–15. · DOI
- LaFountaine, J. S., Fathe, K., & Smyth, H. D. (2015). Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9. International Journal of Pharmaceutics, 494(1), 180–194. · DOI · Paper page
- Benjamin, R., Berges, B. K., Solis-Leal, A., Igbinedion, O., Strong, C. L., & Schiller, M. R. (2016). TALEN gene editing takes aim on HIV. Human Genetics, 135(9), 1059–1070. · DOI
- Janik, E., Niemcewicz, M., Ceremuga, M., Krzowski, L., Saluk-Bijak, J., & Bijak, M. (2020). Various aspects of a gene editing system—crispr–cas9. International Journal of Molecular Sciences, 21(24), 9604. · DOI · Paper page
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821. · DOI · Paper page
- Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987). Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology, 169(12), 5429–5433. · DOI · Paper page
- Khalil, A. M. (2020). The genome editing revolution. Journal of Genetic Engineering and Biotechnology, 18(1), 1–16. · DOI · Paper page
- Wu, W. Y., Lebbink, J. H., Kanaar, R., Geijsen, N., & Van Der Oost, J. (2018). Genome editing by natural and engineered CRISPR-associated nucleases. Nature Chemical Biology, 14(7), 642–651. · DOI
- Baghini, S. S., Gardanova, Z. R., Zekiy, A. O., Shomali, N., Tosan, F., & Jarahian, M. (2021). Optimizing sgRNA to improve CRISPR/Cas9 knockout efficiency: Special focus on human and animal cell. Frontiers in Bioengineering and Biotechnology. https://doi.org/10.3389/fbioe.2021.775309 · DOI
- Uniyal, A. P., Mansotra, K., Yadav, S. K., & Kumar, V. (2019). An overview of designing and selection of sgRNAs for precise genome editing by the CRISPR-Cas9 system in plants. 3Biotech, 9(6), 1–19.
- Liu, P., Liang, S.-Q., Zheng, C., Mintzer, E., Zhao, Y. G., Ponnienselvan, K., Mir, A., Sontheimer, E. J., Gao, G., & Flotte, T. R. (2021). Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nature Communications, 12(1), 1–13. · DOI · Paper page
- Liu, R., Liang, L., Freed, E. F., & Gill, R. T. (2021). Directed evolution of CRISPR/Cas systems for precise gene editing. Trends in Biotechnology, 39(3), 262–273. · DOI
- Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., Van Der Oost, J., & Regev, A. (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163(3), 759–771. · DOI · Paper page
- Bandyopadhyay, A., Kancharla, N., Javalkote, V. S., Dasgupta, S., & Brutnell, T. P. (2020). CRISPR-Cas12a (Cpf1): A versatile tool in the plant genome editing tool box for agricultural advancement. Frontiers in Plant Science, 11, 1589. · DOI · Paper page
- Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., & Marraffini, L. A. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science, 339(6121), 819–823. · DOI · Paper page
- Berber, B., Aydin, C., Kocabas, F., Guney-Esken, G., Yilancioglu, K., Karadag-Alpaslan, M., Caliseki, M., Yuce, M., Demir, S., & Tastan, C. (2021). Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics. Gene Therapy, 28(6), 290–305. · DOI
- Rautela, I., Uniyal, P., Thapliyal, P., Chauhan, N., Sinha, V. B., & Sharma, M. D. (2021). An extensive review to facilitate understanding of CRISPR technology as a gene editing possibility for enhanced therapeutic applications. Gene, 785, 145615. · DOI
- Eid, A., Alshareef, S., & Mahfouz, M. M. (2018). CRISPR base editors: Genome editing without double-stranded breaks. Biochemical Journal, 475(11), 1955–1964. · DOI · Paper page
- Molla, K. A., & Yang, Y. (2019). CRISPR/Cas-mediated base editing: Technical considerations and practical applications. Trends in Biotechnology, 37(10), 1121–1142. · DOI · Paper page
- Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: Advances and therapeutic opportunities. Nature Reviews Drug Discovery, 19(12), 839–859. · DOI · Paper page
- Kim, J.-S. (2018). Precision genome engineering through adenine and cytosine base editing. Nature Plants, 4(3), 148–151. · DOI
- Evanoff, M., & Komor, A. C. (2019). Base editors: Modular tools for the introduction of point mutations in living cells. Emerging Topics in Life Sciences, 3(5), 483–491. · DOI
- Kantor, A., McClements, M. E., & MacLaren, R. E. (2020). CRISPR-Cas9 DNA base-editing and prime-editing. International Journal of Molecular Sciences, 21(17), 6240. · DOI · Paper page
- Rees, H. A., & Liu, D. R. (2018). Base editing: Precision chemistry on the genome and transcriptome of living cells. Nature Reviews Genetics, 19(12), 770–788. · DOI · Paper page
- Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J.-L., Wang, D., & Gao, C. (2017). Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion. Nature Biotechnology, 35(5), 438–440. · DOI · Paper page
- Li, J., Sun, Y., Du, J., Zhao, Y., & Xia, L. (2017). Generation of targeted point mutations in rice by a modified CRISPR/Cas9 system. Molecular Plant, 10(3), 526–529. · DOI · Paper page
- Liang, P., Ding, C., Sun, H., Xie, X., Xu, Y., Zhang, X., Sun, Y., Xiong, Y., Ma, W., & Liu, Y. (2017). Correction of β-thalassemia mutant by base editor in human embryos. Protein & Cell, 8(11), 811–822. · DOI · Paper page
- Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018). Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nature Biotechnology, 36(9), 843–846. · DOI · Paper page
- Musunuru, K., & Kathiresan, S. (2017). Is ANGPTL3 the next PCSK9? Nature Reviews Endocrinology, 13(9), 503–504. · DOI
- Zeng, Y., Li, J., Li, G., Huang, S., Yu, W., Zhang, Y., Chen, D., Chen, J., Liu, J., & Huang, X. (2018). Correction of the Marfan syndrome pathogenic FBN1 mutation by base editing in human cells and heterozygous embryos. Molecular Therapy, 26(11), 2631–2637. · DOI
- Li, X., Qian, X., Wang, B., Xia, Y., Zheng, Y., Du, L., Xu, D., Xing, D., DePinho, R. A., & Lu, Z. (2020). Programmable base editing of mutated TERT promoter inhibits brain tumour growth. Nature Cell Biology, 22(3), 282–288. · DOI
- Lin, X., Chen, H., Lu, Y.-Q., Hong, S., Hu, X., Gao, Y., Lai, L.-L., Li, J.-J., Wang, Z., & Ying, W. (2020). Base editing-mediated splicing correction therapy for spinal muscular atrophy. Cell Research, 30(6), 548–550. · DOI
- Levy, J. M., Yeh, W.-H., Pendse, N., Davis, J. R., Hennessey, E., Butcher, R., Koblan, L. W., Comander, J., Liu, Q., & Liu, D. R. (2020). Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nature Biomedical Engineering, 4(1), 97–110. · DOI · Paper page
- Gaudelli, N. M., Lam, D. K., Rees, H. A., Solá-Esteves, N. M., Barrera, L. A., Born, D. A., Edwards, A., Gehrke, J. M., Lee, S.-J., & Liquori, A. J. (2020). Directed evolution of adenine base editors with increased activity and therapeutic application. Nature Biotechnology, 38(7), 892–900. · DOI · Paper page
- Wu, F., Guo, T., Sun, L., Li, F., & Yang, X. (2022). Base editing of human pluripotent stem cells for modeling long QT syndrome. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-021-10324-6 · DOI
- Rosello, M., Serafini, M., Mignani, L., Finazzi, D., Giovannangeli, C., Mione, M. C., Concordet, J.-P., & Del Bene, F. (2022). Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications, 13(1), 1–13. · DOI
- Huang, S., Zhang, Z., Tao, W., Liu, Y., Li, X., Wang, X., Harati, J., Wang, P.-Y., Huang, X., & Lin, C.-P. (2022). Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA. Molecular Therapy, 30(9), 2923–2932. · DOI
- Huang, X., Wang, Y., & Wang, N. (2022). Base editors for citrus gene editing. Frontiers in Genome Editing. https://doi.org/10.3389/fgeed.2022.852867 · DOI
- Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013). RNA-guided human genome engineering via Cas9. Science, 339(6121), 823–826. · DOI · Paper page
- Bosch, J. A., Birchak, G., & Perrimon, N. (2021). Precise genome engineering in Drosophila using prime editing. Proceedings of the National Academy of Sciences, 118(1), e2021996118. · DOI
- Liu, Y., Li, X., He, S., Huang, S., Li, C., Chen, Y., Liu, Z., Huang, X., & Wang, X. (2020). Efficient generation of mouse models with the prime editing system. Cell Discovery, 6(1), 1–4. · DOI · Paper page
- Sürün, D., Schneider, A., Mircetic, J., Neumann, K., Lansing, F., Paszkowski-Rogacz, M., Hänchen, V., Lee-Kirsch, M. A., & Buchholz, F. (2020). Efficient generation and correction of mutations in human iPS cells utilizing mRNAs of CRISPR base editors and prime editors. Genes, 11(5), 511. · DOI
- Schene, I. F., Joore, I. P., Oka, R., Mokry, M., van Vugt, A. H., van Boxtel, R., van der Doef, H. P., van der Laan, L. J., Verstegen, M., & van Hasselt, P. M. (2020). Prime editing for functional repair in patient-derived disease models. Nature Communications, 11(1), 1–8. · DOI · Paper page
- Anzalone, A. V., Gao, X. D., Podracky, C. J., Nelson, A. T., Koblan, L. W., Raguram, A., Levy, J. M., Mercer, J. A., & Liu, D. R. (2022). Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nature Biotechnology, 40(5), 731–740. · DOI · Paper page
- Ferreira da Silva, J., Oliveira, G. P., Arasa-Verge, E. A., Kagiou, C., Moretton, A., Timelthaler, G., Jiricny, J., & Loizou, J. I. (2022). Prime editing efficiency and fidelity are enhanced in the absence of mismatch repair. Nature Communications, 13(1), 1–11. · DOI · Paper page
- Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J., & Marra, G. (2002). Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology, 122(1), 211–219. · DOI · Paper page
- Gupta, S., Gellert, M., & Yang, W. (2012). Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops. Nature Structural & Molecular Biology, 19(1), 72–78. · DOI · Paper page
- Koeppel, J., Peets, E. M., Weller, J., Pallaseni, A., Liberante, F., & Parts, L. (2021). Predicting efficiency of writing short sequences into the genome using prime editing. bioRxiv. https://doi.org/10.1101/2021.11.10.468024 · DOI
- Chen, P. J., Hussmann, J. A., Yan, J., Knipping, F., Ravisankar, P., Chen, P. F., Chen, C., Nelson, J. W., Newby, G. A., & Sahin, M. (2021). Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell, 184(22), 5635-5652.e5629. · DOI · Paper page
- Hsu, J. Y., Grünewald, J., Szalay, R., Shih, J., Anzalone, A. V., Lam, K. C., Shen, M. W., Petri, K., Liu, D. R., & Joung, J. K. (2021). PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nature Communications, 12(1), 1–6. · DOI · Paper page
- Nelson, J. W., Randolph, P. B., Shen, S. P., Everette, K. A., Chen, P. J., Anzalone, A. V., An, M., Newby, G. A., Chen, J. C., & Hsu, A. (2022). Engineered pegRNAs improve prime editing efficiency. Nature Biotechnology, 40(3), 402–410. · DOI · Paper page
Cited by
p53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Saber Sichani, A., Ranjbar, M., Baneshi, M., Torabi Zadeh, F., & Fallahi, J.
- Venue
- Molecular Biotechnology
- Published
- 2022-12-22
- Volume
- 65
- Issue
- 6
- Pages
- 849-860
- ISSN
- 1073-6085
- 1559-0305
- Cited by
- 97
- References
- 22
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing. https://app.cochat.ai/papers/10.1007/s12033-022-00639-1
- The paper
- Saber Sichani, A., Ranjbar, M., Baneshi, M., Torabi Zadeh, F., & Fallahi, J. (2023). A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing. Molecular Biotechnology. https://doi.org/10.1007/s12033-022-00639-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.